Suchergebnisse - "Wedde, Marianne"

PubPharm (42)

11

Molecular characterization and evolution dynamics of influenza B viruses circulating in Germany from season 1996/1997 to 2019/2020

enthalten in: Virus research | 2022

von Heider, A. | Wedde, M. | Dürrwald, R. | +2

12

Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Oh, D. | Hölzer, M. | Paraskevopoulou, S. | +46

13

Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2022

von Melidou, A. | Ködmön, C. | Nahapetyan, K. | +36

14

Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020 : Analysis of national surveillance data

enthalten in: The Lancet regional health. Europe | 2021

von Oh, D. | Buda, S. | Biere, B. | +8

15

Zoonotic infection with swine A/H1avN1 influenza virus in a child, Germany, June 2020

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2020

von Dürrwald, R. | Wedde, M. | Biere, B. | +13

16

Interim 2019/20 influenza vaccine effectiveness : six European studies, September 2019 to January 2020

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2020

von Rose, A. | Kissling, E. | Emborg, H. | +108

17

Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18" [Vaccine 35 (2017) 4828-4835

enthalten in: Vaccine | 2018

von Melidou, A. | Broberg, E. | European region influenza surveillance network | +100

ErratumFor: Vaccine. 2017 Sep 5;35(37):4828-4835. - PMID 28780977

18

Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2) : I-MOVE multicentre case control studies at primary care and hospital levels in Europe

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2017

von Kissling, E. | Rondy, M. | I-MOVE/I-MOVE+ study team | +100

19

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2016

von Valenciano, M. | Kissling, E. | Reuss, A. | +44

ErratumIn: Euro Surveill. 2016;21(8). doi: 10.2807/1560-7917.ES.2016.21.8.30145. - PMID 26939540

20

Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2016

von Broberg, E. | Melidou, A. | Prosenc, K. | +103